http://rdf.ncbi.nlm.nih.gov/pubchem/reference/11297813

Outgoing Links

Predicate Object
contentType Journal Article|Review
endingPage 121
issn 1744-8379
1473-7167
issueIdentifier 2
pageRange 117-121
publicationName Expert Review of Pharmacoeconomics & Outcomes Research
startingPage 117
bibliographicCitation Taylor MJ, Scuffham PA. Pharmacoeconomic benefits of dasatinib in the treatment of imatinib-resistant patients with chronic myelogenous leukemia. Expert Review of Pharmacoeconomics & Outcomes Research. 2009 Apr;9(2):117–21. doi: 10.1586/erp.09.1.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4f0b180a5f9ef91b3189190eeabb8350
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bdb6d750a25c25b3119e9c448a4493f7
date 200904
identifier https://doi.org/10.1586/erp.09.1
https://pubmed.ncbi.nlm.nih.gov/19402798
isPartOf https://portal.issn.org/resource/ISSN/1744-8379
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/35734
https://portal.issn.org/resource/ISSN/1473-7167
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Pharmacoeconomic benefits of dasatinib in the treatment of imatinib-resistant patients with chronic myelogenous leukemia
discusses http://id.nlm.nih.gov/mesh/M0001483
http://id.nlm.nih.gov/mesh/M0457532
http://id.nlm.nih.gov/mesh/M0018260
http://id.nlm.nih.gov/mesh/M0016884
http://id.nlm.nih.gov/mesh/M0391958
http://id.nlm.nih.gov/mesh/M0002327
http://id.nlm.nih.gov/mesh/M0021333
http://id.nlm.nih.gov/mesh/M0470497
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D015464Q000188
http://id.nlm.nih.gov/mesh/D000970Q000627
http://id.nlm.nih.gov/mesh/D011743Q000191
http://id.nlm.nih.gov/mesh/D010879Q000191
http://id.nlm.nih.gov/mesh/D011743Q000627
http://id.nlm.nih.gov/mesh/D000970Q000191
http://id.nlm.nih.gov/mesh/D013844Q000627
http://id.nlm.nih.gov/mesh/D015464Q000191
http://id.nlm.nih.gov/mesh/D010879Q000627
http://id.nlm.nih.gov/mesh/D047428Q000627
http://id.nlm.nih.gov/mesh/D047428Q000191
http://id.nlm.nih.gov/mesh/D013844Q000191
hasSubjectTerm http://id.nlm.nih.gov/mesh/D013844Q000009
http://id.nlm.nih.gov/mesh/D011743Q000009
http://id.nlm.nih.gov/mesh/D000818
http://id.nlm.nih.gov/mesh/D016896
http://id.nlm.nih.gov/mesh/D000068877
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D001549
http://id.nlm.nih.gov/mesh/D019008
http://id.nlm.nih.gov/mesh/D003365
http://id.nlm.nih.gov/mesh/D047428Q000009
http://id.nlm.nih.gov/mesh/D011788
http://id.nlm.nih.gov/mesh/D000069439
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9727
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129879136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128433595

Total number of triples: 59.